EdgarLookup

Apollo Global Management, Inc. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that Apollo Global Management, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
10.9%
Profit Margin
Net income ÷ revenue
0.8%
Return on Assets
Net income ÷ assets
17.93x
Debt-to-Equity
Total liabilities ÷ equity
+22.7%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $32.05B Feb 25, 2026
FY2025 Dec 31, 2024 $26.11B Feb 25, 2026
FY2025 Dec 31, 2023 $32.64B Feb 25, 2026
FY2023 Mar 31, 2023 $5.30B May 9, 2023
FY2023 Dec 31, 2022 $4.84B Feb 27, 2024
FY2023 Sep 30, 2022 $2.98B Feb 27, 2024
FY2023 Jun 30, 2022 $2.29B Feb 27, 2024
FY2023 Mar 31, 2022 $862.00M Feb 27, 2024
FY2023 Dec 31, 2021 $5.95B Feb 27, 2024
FY2022 Dec 31, 2020 $2.35B Mar 1, 2023

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $3.49B Feb 25, 2026
FY2025 Dec 31, 2024 $4.58B Feb 25, 2026
FY2025 Dec 31, 2023 $5.05B Feb 25, 2026
FY2023 Dec 31, 2022 $640.00M Feb 27, 2024
FY2023 Sep 30, 2022 ($563.00M) Feb 27, 2024
FY2023 Jun 30, 2022 ($1.64B) Feb 27, 2024
FY2023 Mar 31, 2022 ($401.00M) Feb 27, 2024
FY2023 Dec 31, 2021 $1.84B Feb 27, 2024
FY2022 Dec 31, 2020 $157.00M Mar 1, 2023

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $7.25B Feb 25, 2026
FY2025 Dec 31, 2024 $3.25B Feb 25, 2026
FY2025 Dec 31, 2023 $6.32B Feb 25, 2026
FY2023 Mar 31, 2023 $1.07B May 9, 2023
FY2024 Dec 31, 2022 $3.79B Feb 24, 2025
FY2023 Mar 31, 2022 ($3.99B) May 9, 2023
FY2023 Dec 31, 2021 $1.06B Feb 27, 2024
FY2022 Dec 31, 2020 ($1.62B) Mar 1, 2023

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $460.95B Feb 25, 2026
FY2025 Dec 31, 2024 $377.90B Feb 25, 2026
FY2024 Dec 31, 2023 $313.49B Feb 24, 2025
FY2023 Mar 31, 2023 $270.32B May 9, 2023
FY2023 Dec 31, 2022 $257.22B Feb 27, 2024
FY2022 Dec 31, 2021 $30.50B Mar 1, 2023

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $418.43B Feb 25, 2026
FY2025 Dec 31, 2024 $346.92B Feb 25, 2026
FY2024 Dec 31, 2023 $288.24B Feb 24, 2025
FY2023 Mar 31, 2023 $252.59B May 9, 2023
FY2023 Dec 31, 2022 $241.82B Feb 27, 2024
FY2022 Dec 31, 2021 $18.54B Mar 1, 2023

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $23.34B Feb 25, 2026
FY2025 Dec 31, 2024 $17.25B Feb 25, 2026
FY2024 Dec 31, 2023 $14.04B Feb 24, 2025
FY2023 Mar 31, 2023 $8.07B May 9, 2023
FY2023 Dec 31, 2022 $6.64B Feb 27, 2024
FY2022 Dec 31, 2021 $3.79B Mar 1, 2023

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $5.92B Feb 25, 2026
FY2025 Dec 31, 2024 $4.33B Feb 25, 2026
FY2024 Dec 31, 2023 $4.33B Feb 24, 2025
FY2023 Dec 31, 2022 $4.32B Feb 27, 2024
FY2022 Dec 31, 2021 $117.00M Mar 1, 2023

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $7.63B Feb 25, 2026
FY2025 Dec 31, 2024 $6.02B Feb 25, 2026
FY2024 Dec 31, 2023 $2.97B Feb 24, 2025
FY2023 Mar 31, 2023 ($172.00M) May 9, 2023
FY2023 Dec 31, 2022 ($1.01B) Feb 27, 2024
FY2022 Dec 31, 2021 $1.14B Mar 1, 2023

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2023 Mar 31, 2023 $15.10B May 9, 2023
FY2022 Dec 31, 2022 $8.98B Mar 1, 2023
FY2023 Mar 31, 2022 $9.77B May 9, 2023
FY2022 Dec 31, 2021 $917.00M Mar 1, 2023
FY2022 Dec 31, 2020 $1.56B Mar 1, 2023

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $13.36B Feb 25, 2026
FY2025 Dec 31, 2024 $10.59B Feb 25, 2026
FY2024 Dec 31, 2023 $8.09B Feb 24, 2025
FY2023 Mar 31, 2023 $6.46B May 9, 2023
FY2023 Dec 31, 2022 $6.47B Feb 27, 2024
FY2022 Dec 31, 2021 $3.13B Mar 1, 2023

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 5 Feb 25, 2026
FY2025 Dec 31, 2024 7 Feb 25, 2026
FY2025 Dec 31, 2023 8 Feb 25, 2026
FY2023 Mar 31, 2023 1 May 9, 2023
FY2024 Dec 31, 2022 (3) Feb 24, 2025
FY2023 Mar 31, 2022 0 May 9, 2023
FY2023 Dec 31, 2021 7 Feb 27, 2024
FY2022 Dec 31, 2020 0 Mar 1, 2023

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 5 Feb 25, 2026
FY2025 Dec 31, 2024 7 Feb 25, 2026
FY2025 Dec 31, 2023 8 Feb 25, 2026
FY2023 Mar 31, 2023 1 May 9, 2023
FY2024 Dec 31, 2022 (3) Feb 24, 2025
FY2023 Mar 31, 2022 0 May 9, 2023
FY2023 Dec 31, 2021 7 Feb 27, 2024
FY2022 Dec 31, 2020 0 Mar 1, 2023

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 578.98M Feb 25, 2026
FY2025 Dec 31, 2024 565.74M Feb 25, 2026
FY2024 Dec 31, 2023 567.76M Feb 24, 2025
FY2023 Mar 31, 2023 567.39M May 9, 2023
FY2023 Dec 31, 2022 570.28M Feb 27, 2024

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.20B Feb 25, 2026
FY2025 Dec 31, 2024 $1.09B Feb 25, 2026
FY2025 Dec 31, 2023 $1.01B Feb 25, 2026
FY2023 Mar 31, 2023 $241.00M May 9, 2023
FY2024 Dec 31, 2022 $962.00M Feb 24, 2025
FY2023 Mar 31, 2022 $229.00M May 9, 2023
FY2023 Dec 31, 2021 $517.00M Feb 27, 2024
FY2022 Dec 31, 2020 $550.00M Mar 1, 2023